Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 28, 2019; 25(16): 2010-2018
Published online Apr 28, 2019. doi: 10.3748/wjg.v25.i16.2010
Published online Apr 28, 2019. doi: 10.3748/wjg.v25.i16.2010
Age in yr/sex | Location of GIST | Metabolic activity with SUVmax in GIST | Primary surgery | Genotype of GIST | Imatinib for GIST | Interval1 (mo) | Metabolic activity with SUVmax in DT | Sites of DT | Surgery for DT | Size (cm) of DT2 | Patient status | |
1 | 59/F | Stomach | - | W/R | KIT exon 11 | No | 31.5 | 3.5 | Peritoneum, celiac area | Open biopsy | 3.7 | F/U loss |
2 | 63/F | Sigmoid | 4.3 | LAR | KIT exon 9 | Yes | 13.9 | 2.2 | Peritoneum, pelvic area | SB R and A, mass excision | 2 | Recurrence of GIST |
3 | 58/M | Stomach | - | W/R | - | Yes | 23.7 | No | Peritoneum, LUQ area | Lap. W/R of stomach, mass excision | 1.7 | NED |
4 | 50/M | Stomach | - | TG | - | Yes | 20.3 | - | Peritoneum, pelvic area | SB R and A, mass excision | 6.7 | NED |
5 | 67/M | Duodenum | 6.33 | PPPD | - | Yes | 13.5 | No | Peritoneum, pelvic area | Excision of SB mesentery | 2.2 | Recurrence of GIST |
6 | 56/M | Jejunum | - | Seg. resection | - | Yes | 10.9 | 3.2 | Peritoneum, pelvic area | SB R and A | 3 | Recurrence of DT |
7 | 40/F | SB with peritoneum, liver, ovary | - | SB R and A | KIT exon 11 | Yes | 28.5 | 2.7 | Peritoneum, pelvic area | SB R and A | 3.3 | Stable GIST with imatinib |
8 | 72/M | Stomach, recurrent SB with peritoneum | 4.9 | Lap. W/R | - | Yes | 84.6 | - | Peritoneum, adrenal area | Mass excision | 1.3 | Stable GIST with imatinib |
Previous cases1 (n = 27) | Present cases (n = 8) | |
Sex (Male : Female) | 19:7 (one patient; unknown) | 5:3 |
Age (yr) (median, range) | 58 (34-74) | 58.5 (40-72) |
Primary GIST | ||
Stomach | 20 | 4 |
Small bowel | 11 | 3 |
Peritoneum | 2 | 0 |
Colon and rectum | 0 | 1 |
Disease status following the occurrence of a new single lesion | 62 | 8 |
Localized GIST | 5 | 6 |
Metastatic GIST | 1 | 2 |
Imatinib for GIST following the occurrence of a new single lesion | 19 | 7 |
Interval time from surgical resection of GIST to the diagnosis of DT (yr) | 2.5 (0.5-15.9) | 1.8 (0.9-7.1) |
Sites of DT | ||
Stomach | 1 | - |
Small bowel | 5 | - |
Colon | 1 | - |
Peritoneum/Mesentery | 15 | 8 |
Others (liver and spleen) | 2 | - |
Extra-abdominal organ3 | 3 | - |
Size of DT (cm) (median, range) | 6.5 (1.6–17)4 | 2.6 (1.3-6.7) |
- Citation: Kim JH, Ryu MH, Park YS, Kim HJ, Park H, Kang YK. Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors — 8 cases: A case report. World J Gastroenterol 2019; 25(16): 2010-2018
- URL: https://www.wjgnet.com/1007-9327/full/v25/i16/2010.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i16.2010